Live Breaking News & Updates on Coronavirus strain

Stay informed with the latest breaking news from Coronavirus strain on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Coronavirus strain and stay connected to the pulse of your community

Why start vaccination centres with pomp if second jab of Covaxin not available, HC asks Delhi govt

Delhi High Court also issued notice to the Centre on two pleas to make the second dose of both vaccines against COVID-19 — Covaxin and Covishield — available in the national capital

Uttar-pradesh , India , Delhi , Meerut , Anuj-aggarwal , Ashish-virmani , Pallav-mongia , Justice-rekha-palli , Delhi-high-court-on , Delhi-high-court , Rekha-palli

B1617 COVID-19 Variant Spreading Rapidly: Are You At Risk Too?

A new Covid-19 variant has become a new 'cause of concern' for the world after experts said that this strain is twice more transmissible than original one.

India , About-the , Coronavirus-strain , Ovid-strain , Ovid-new-strain , Ovid-19-variant , Ndian-covi-variant , இந்தியா , -தி ,

Vietnam Detects New COVID-19 Variant, Hybrid Of Strains Found In India, UK

Vietnam has discovered a new COVID-19 variant which spreads quickly by air and is a combination of the strains first found in India and Britain, health officials confirmed Saturday.

India , Vietnam , Republic-of , Thailand , Egypt , Ho-chi-minh-city , H-chíinh , United-kingdom , Ministry-of-health , Al-qahirah , Hanoi , Han-i

B.1.617 variant of SARS-CoV2 has sub-lineages; B.1.617.2 more infectious: Expert | India News


NEW DELHI: The double mutant B.1.617 variant of SARS-CoV2 is further mutating and one of its sub-lineages, the B.1.617.2, reported in India, is more infectious than its parent and fast increasing its footprint, Rakesh Mishra, former director of the Centre for Cellular and Molecular Biology, said on Wednesday.
He also said there is nothing called the “Singapore variant”, a term that has led to a war of words between the Centre and the AAP government after Singapore objected to chief minister Arvind Kejriwal's tweet that a "new" coronavirus strain in the city-state is very dangerous for children.
Singapore's health ministry on Tuesday night said the strain that is prevalent in many of the Covid-19 cases in recent weeks is the B.1.617.2 variant, which was first detected in India.

Karnataka , India , Delhi , United-kingdom , Singapore , Rakesh-mishra , Sujeet-singh , Arvind-kejriwal , Centre-for-cellular , Centre-for-disease , National-centre-for-disease , World-health-organisation

COVID-19 surge: Bihar, U.P., Delhi top list of deaths among doctors in second wave, says IMA


“While last year we lost nearly 730 doctors across India, this year in a short period of time we have lost 244 doctors. The second wave is proving extremely fatal for all and especially those at the forefront of the battle. We have to actively increase vaccination cover among the medical staff to ensure that they have protection against the virus,’’ said IMA president J.A. Jayalal.
The following are the figures of fatalities according to the IMA registry: Andhra Pradesh (21), Telangana (19), Maharashtra (13), Tamil Nadu (10), Karnataka and Odisha (8 each), Madhya Pradesh (5), Chhattisgarh and Jammu and Kashmir (3 each), Assam, Gujarat, Haryana and Kerala (2 each) and Goa (1).

India , Kolkata , West-bengal , Uttar-pradesh , Delhi , Bihar , Kumar-rakshit , Anas-mijahid , States-union-territories , Indian-medical-association , Union-territories , Anil-kumar-rakshit

Govt. releases DRDO's COVID drug for emergency use


Updated:
Developed with DRL, it reduces oxygen-dependence in patients
Share Article
AAA
Defence Minister Rajnath Singh hands over the first batch of 2-DG anti Covid drug to the Union Health Minister Harsh Vardhan, in New Delhi on May 17, 2021. Photo: Twitter/@rajnathsingh
 
Developed with DRL, it reduces oxygen-dependence in patients
The first batch of the adjunct COVID therapy drug, 2-deoxy-D-glucose (2-DG) — developed by the Defence Research and Development Organisation (DRDO) along with Dr Reddy’s Laboratories (DRL), Hyderabad — was on Monday released for emergency use. Defence Minister Rajnath Singh formally handed over the drug to Health Minister Dr Harsh Vardhan.
“One box each of the sachets of the drug were handed over to Dr. Randeep Guleria, Director All India Institute of Medical Sciences (AIIMS) and Lt. Gen. Sunil Kant of Armed Forces Medical Services (AFMS). More will be handed over to different hospitals across the country for emergency use,” a Defence Ministry statement said.

Uttar-pradesh , India , Karnataka , Delhi , Hyderabad , Andhra-pradesh , Telangana , Tamil-nadu , Harsh-vardhan , Rajnath-singh , G-satheesh-reddy , Sunil-kant

COVID-19 surge: Lockdown in Delhi extended for another week

‘We need to extend the lockdown as we cannot afford to lose the gains made so far in combating the virus,’ says CM Arvind Kejriwal

Delhi , India , Delhi-disaster-management-authority , Chief-minister-arvind-kejriwal , Delhi-metro , New-delhi , Arvind-kejriwal , Lockdown-extension , Corona-virus , Covishield , Covaxin